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severity—proximal isolated stenoses ver-
sus multiple stenoses with distal vessel in-
volvement—are features of coronary artery
disease that strongly influence surgical
strategy, complexity of the operation, and
prognosis. Moreover, the quality of coro-
nary vessels and graft availability and qual-
ity determine the completeness of the
revascularization and its durability. With
the matching method adopted by Brown
and colleagues,1 these data are lost to the
analysis, making it impossible to evaluate
any effects on the higher perioperative
and long-term mortalities observed in the
bioprosthesis group. Higher mortality
could be related to an unfavorable preoper-
ative status. In that case, the surgeons who
performed the operations may have shown
good clinical judgment, implanting bio-
prostheses in patients with poor prognosis.
Moreover, there are no data on prosthesis
sizes, effective orifice areas, and the inci-
dence of patient–prosthesis mismatch, all
of which could influence long-term results.
In conclusion, Brown and colleagues de-
serve commendation for the insights from
their interesting study. Nevertheless, ex-
treme caution should be exercised in sup-
porting or questioning existing clinical
guidelines in response to potentially biased
retrospective studies.
Aldo Cannata, MD
Claudio Francesco Russo, MD
Corrado Taglieri, MD
Angelo De Gasperis Department of Cardiac
Surgery Niguarda Ca` Granda Hospital
Milan, Italy
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Importance of stabilization of
the mitral annulus in mitral valve
repair
To the Editor:
We read with great interest the article of
Flameng and coauthors1 about their expe-
riences with mitral valve repair in Barlow
disease and fibroelastic deficiency. They
found that not using annuloplasty ring
in mitral valve repair is a risk factor for
recurrent mitral valve regurgitation. We
Letters to the EditorReply to the Editor:
Drs Cannata, Russo, and Taglieri com-
mented on our results and the possible
impact of selection bias, which is present
in all observational surgical series. We
matched patients and used multivariate anal-
yses, but it is impossible to determine
whether this has accounted for all possible
confounders. We agree that only randomiza-1102 The Journal of Thoracic and Cardiov0
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Figure 1. Survivals in mechanical aortic valve (Mech V) and bioprosthetic aortic valve
(BPV) groups according to presence or absence of coronary artery disease, as indicated
by coronary artery bypass grafting (CABG).tion can distribute unmeasured covariates
evenly between groups.
A question was raised regarding the
extent of coronary artery disease. We
used coronary artery bypass grafting as
a surrogate for coronary artery disease,
and the mean numbers of grafts per patient
were 1.0 6 1.3 in the mechanical aortic
valve group and 1.0 6 1.2 in the biopros-
thetic aortic valve group (P 5 .86). We
performed an analysis of survival of pa-
tients undergoing aortic valve replacement
with and without coronary artery bypass
grafting (Figure 1). The survival benefit
we observed with a mechanical aortic
valve appears, however, to be independent
of the presence of coronary artery disease
in our multivariate model, as shown in
Table 5 of our original article.1
Our finding of a survival benefit in the
mechanical aortic valve group was surpris-
ing, and we have hypothesized that one
possible explanation would be patient–pros-
thesis mismatch. We do not have the effec-
tive orifice area data available for this
study group. We have, however, included
information regarding body surface area
and body mass index, size of prosthesis,
and the incidence of aortic root enlargement
in each group (see Table 1 in our original ar-
ticle). In general, surgeons at our clinic
perform aortic root enlargement to accom-
modate a larger prostheses in any patient
who is at risk for patient–prosthesis mis-
match.2
We believe that current guidelines are
generally appropriate for mechanical or bio-
prosthetic valve selection. Our primaryascular Surgery c October 2008concern is with the growing trend toward
placing bioprosthetic aortic valves in youn-
ger patients. All observational (retrospective
or prospective) studies are unable to elimi-
nate the potential impact of patient selection
bias; however, this investigation adds equi-
poise.
Morgan Brown, MD
Hartzell Schaff, MD
Division of Cardiovascular Surgery, Mayo
Clinic, Rochester, MN
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